v3.25.1
Material accounting policy information - Additional Information (Detail)
 6 Months Ended
Dec. 31, 2024
AUD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
AUD ($)
Dec. 31, 2022
AUD ($)
Mar. 30, 2025
USD ($)
Jun. 30, 2024
AUD ($)
May 01, 2022
AUD ($)
Disclosure of summary of significant accounting policies [line items]              
Consolidated loss after income tax $ 10,453,811   $ 8,823,513 $ 8,823,513      
Net current liability position 13,105,757         $ 19,652,664  
Net cash outflows from operating activities 8,420,244     $ 6,334,872      
Proceeds from issuing shares $ 8,561,589   $ 1,327,468        
At The Market Equity Program [Member]              
Disclosure of summary of significant accounting policies [line items]              
Aggregate offering             $ 35,000,000
Number of shares represented by one depositary receipt 100            
Proceeds from issuing shares   $ 4,190,155          
Proceeds from issue of ordinary shares   36,900,000          
Events After Reporting Period [Member]              
Disclosure of summary of significant accounting policies [line items]              
Number of shares represented by one depositary receipt 500            
Consolidated entity generated on the sale of cantrixil patents and trademarks         $ 1,000,000    
Major Ordinary Share Transactions [Member] | At The Market Equity Program [Member]              
Disclosure of summary of significant accounting policies [line items]              
Proceeds from issue of ordinary shares $ 2,496,182 $ 12,888,123